BHVN · Categories · Form 4
BHVN - SEC Form 4 insider transactions
Biohaven Ltd. (BHVN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for BHVN
- SEC Form 4 filed by Director Mehta Kishan4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Director Bailey Gregory4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Director Heffernan Michael Thomas4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Director Antonijevic Irina4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Director Childs John W4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Director Hugin Robert J4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Director Gregory Julia P4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Mehta Kishan4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Buten Matthew4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by SVP, Clinical Operations Gentile Kimberly4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by VP, Chief Accounting Officer Clark George C.4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Car Bruce4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Coric Vlad4 - Biohaven Ltd. (0001935979) (Issuer)
- SVP, Clinical Operations Gentile Kimberly covered exercise/tax liability with 1,956 shares and converted options into 3,750 shares, increasing direct ownership by 2% to 99,557 units (SEC Form 4)4 - Biohaven Ltd. (0001935979) (Issuer)
- Chief Financial Officer Buten Matthew converted options into 4,250 shares and covered exercise/tax liability with 2,594 shares, increasing direct ownership by 0.85% to 195,652 units (SEC Form 4)4 - Biohaven Ltd. (0001935979) (Issuer)
- Chief Executive Officer Coric Vlad converted options into 14,250 shares and covered exercise/tax liability with 7,430 shares, increasing direct ownership by 0.38% to 1,803,968 units (SEC Form 4)4 - Biohaven Ltd. (0001935979) (Issuer)
- Chief Scientific Officer Car Bruce converted options into 4,750 shares and covered exercise/tax liability with 2,381 shares, increasing direct ownership by 44% to 7,715 units (SEC Form 4)4 - Biohaven Ltd. (0001935979) (Issuer)
- VP, Chief Accounting Officer Clark George C. covered exercise/tax liability with 1,117 shares and converted options into 2,500 shares, increasing direct ownership by 2% to 66,978 units (SEC Form 4)4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Director Antonijevic Irina4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Director Heffernan Michael Thomas4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Director Bailey Gregory4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Director Mehta Kishan4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Director Gregory Julia P4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Director Childs John W4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Director Hugin Robert J4 - Biohaven Ltd. (0001935979) (Issuer)
- Chief Scientific Officer Car Bruce converted options into 4,750 shares and covered exercise/tax liability with 2,331 shares, increasing direct ownership by 102% to 4,802 units (SEC Form 4)4 - Biohaven Ltd. (0001935979) (Issuer)
- SVP, Clinical Operations Gentile Kimberly converted options into 3,750 shares and covered exercise/tax liability with 1,956 shares, increasing direct ownership by 2% to 97,763 units (SEC Form 4)4 - Biohaven Ltd. (0001935979) (Issuer)
- VP, Chief Accounting Officer Clark George C. converted options into 2,500 shares and covered exercise/tax liability with 1,117 shares, increasing direct ownership by 2% to 65,051 units (SEC Form 4)4 - Biohaven Ltd. (0001935979) (Issuer)
- Chief Financial Officer Buten Matthew converted options into 4,250 shares and covered exercise/tax liability with 2,561 shares, increasing direct ownership by 0.88% to 193,452 units (SEC Form 4)4 - Biohaven Ltd. (0001935979) (Issuer)
- Chief Executive Officer Coric Vlad converted options into 14,250 shares and covered exercise/tax liability with 6,805 shares, increasing direct ownership by 0.42% to 1,796,604 units (SEC Form 4)4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Mehta Kishan4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Heffernan Michael Thomas4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Gregory Julia P4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Hugin Robert J4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Antonijevic Irina4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Childs John W4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4 filed by Bailey Gregory4 - Biohaven Ltd. (0001935979) (Issuer)
- Childs John W was granted 2,091 shares (SEC Form 4)4 - Biohaven Ltd. (0001935979) (Issuer)
- Coric Vlad was granted 694 shares, increasing direct ownership by 0.01% to 1,666,466 units (SEC Form 4)4 - Biohaven Ltd. (0001935979) (Issuer)
- Childs John W was granted 19,412 shares (SEC Form 4)4 - Biohaven Ltd. (0001935979) (Issuer)
- Coric Vlad was granted 6,472 shares, increasing direct ownership by 0.13% to 1,666,234 units (SEC Form 4)4 - Biohaven Ltd. (0001935979) (Issuer)
- SEC Form 4: Biohaven Pharmaceutical Holding Co Ltd. acquired 35,839,857 shares and disposed of 35,839,857 shares4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Reporting)
- SEC Form 4: Engelhart James returned $2,361,150 worth of shares to the company (15,900 units at $148.50), closing all direct ownership in the company to satisfy withholding obligation4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4: Childs John W returned $450,697,648 worth of shares to the company (3,035,001 units at $148.50), closing all direct ownership in the company (withholding obligation)4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4: Buten Matthew returned $917,284 worth of shares to the company (6,177 units at $148.50), closing all direct ownership in the company (for withholding tax)4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4: Mehta Kishan returned $1,580,040 worth of shares to the company (10,640 units at $148.50), closing all direct ownership in the company (withholding tax)4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4: Tilton John returned $992,277 worth of shares to the company (6,682 units at $148.50), decreasing direct ownership by 76% to 1,614 units (for tax liability)4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4 filed by Heffernan Michael Thomas to cover withholding tax4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4: Coric Vlad returned $137,056,738 worth of shares to the company (922,941 units at $148.50), decreasing direct ownership by 10% to 830,891 units to satisfy withholding tax4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4: Jones William A Jr returned $2,112,561 worth of shares to the company (14,226 units at $148.50), closing all direct ownership in the company (withholding obligation)4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4 filed by Gregory Julia P to satisfy withholding obligation4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4 filed by Antonijevic Irina to satisfy withholding tax4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4: Hugin Robert J returned $430,650 worth of shares to the company (2,900 units at $148.50), closing all direct ownership in the company (tax liability)4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4: Clark George C. returned $637,362 worth of shares to the company (4,292 units at $148.50), closing all direct ownership in the company to satisfy tax liability4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4: Stock Elyse returned $2,444,904 worth of shares to the company (16,464 units at $148.50), closing all direct ownership in the company to satisfy withholding tax4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4: Bailey Gregory returned $383,673,213 worth of shares to the company (2,583,658 units at $148.50), closing all direct ownership in the company (withholding obligation)4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4: Conway Charles returned $3,320,757 worth of shares to the company (22,362 units at $148.50), closing all direct ownership in the company (for tax liability)4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4: Gentile Kimberly returned $1,730,470 worth of shares to the company (11,653 units at $148.50), closing all direct ownership in the company to cover withholding tax4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4: Bailey Gregory bought $5,625,676 worth of shares (38,000 units at $148.04), increasing direct ownership by 1% to 2,583,658 units4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)
- SEC Form 4: Clark George C. sold $594,300 worth of shares (4,200 units at $141.50) as part of a pre-agreed trading plan and exercised 2,250 shares at a strike of $53.76, decreasing direct ownership by 32% to 4,065 units4 - Biohaven Pharmaceutical Holding Co Ltd. (0001689813) (Issuer)